Search

everythinglearnresearchcommunity

for

Search:↓

Geriatric Julia Creek dunnarts often suffer from reproductive and skin diseases, impacting conservation efforts.

The document concludes that veterinary dermatologists need more experience and a better approach to treating skin diseases in nonhuman primates.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Non-viral delivery systems and stimuli-responsive nanoformulations can improve CRISPR-Cas9 gene therapy.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

High doses of albendazole can be deadly for alpacas.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Plasma therapy is becoming more popular for treating viral infections, skin conditions, and orthopedic issues, and is expected to grow in the healthcare market.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Polyomavirus A2 infection in newborn mice caused hair follicle tumors.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Some patients with hair loss after mild COVID-19 had positive tests for certain autoantibodies.

Many Egyptian women who were hospitalized for COVID-19 experienced significant hair loss afterwards.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

The patient improved after antiviral treatment for a viral infection.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

COVID-19 vaccines do not increase the risk of alopecia areata.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.